New study aims to fill gaps in lymphoma care in africa
NCT ID NCT02835911
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study is creating a large registry of 800 lymphoma patients in Malawi to collect detailed information about the disease. Researchers will perform biopsies and track patients over time to understand how lymphoma affects people in sub-Saharan Africa. The goal is to gather data that is currently missing, which could improve future care.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- What this could lead to
- If successful, this study could provide crucial data on lymphoma in sub-Saharan Africa, potentially guiding better diagnosis and treatment strategies for the region.
- What could go wrong
- This is an observational registry, not a treatment trial, so it won't directly benefit participants. Data collection may face challenges like patient follow-up or limited resources.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCIES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UNC Project
RECRUITINGLilongwe, Malawi
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict blood cancer outcomes?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can engineered immune cells tackle brain lymphoma?
- Talking about the end: could guided conversations reduce futile cancer treatments?
- A simple blood test may reveal hidden infertility risk in young cancer survivors
- Can a targeted pill boost Chemotherapy's punch against lymphoma?